ppt chapter 57
DESCRIPTION
TRANSCRIPT
![Page 1: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/1.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drugs Affecting Gastrointestinal Secretions
Drugs Affecting Gastrointestinal Secretions
Chapter 57
![Page 2: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/2.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Underlying Causes of GI DisordersUnderlying Causes of GI Disorders• Dietary Excess
• Stress
• Hiatal Hernia
• Esophageal Reflux
• Adverse Drug Effects
• Peptic Ulcer Disease
![Page 3: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/3.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Effect of Drugs on GI SecretionsEffect of Drugs on GI Secretions• Decrease GI secretory activity
• Block the action of GI secretions
• Form protective coverings on the GI lining to prevent erosion from GI secretions
• Replace missing GI enzymes that the GI tract or ancillary glands and organs can no longer produce
![Page 4: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/4.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Peptic Ulcer DiseasePeptic Ulcer Disease• Definition
– Erosions in the lining of the stomach and adjacent areas of the GI tract
• Symptoms
– Gnawing, burning pain, often occurring after meals
• Cause
– Bacterial infection by Helicobacter pylori bacteria
![Page 5: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/5.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drugs Used in the Treatment of UlcersDrugs Used in the Treatment of Ulcers
• Histamine-2 (H2) Antagonists
– Block the release of hydrochloric acid in response to gastrin
• Antacids
– Interact with acids at the chemical level to neutralize them
• Proton Pump Inhibitors
– Suppress the secretion of hydrochloric acid into the lumen of the stomach
![Page 6: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/6.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drugs Used in the Treatment of Ulcers (cont.)
Drugs Used in the Treatment of Ulcers (cont.)
• Antipeptic Agents
– Coat any injured area in the stomach to prevent further injury from acid
• Prostaglandins
– Inhibit the secretion of gastrin and increase the secretion of the mucous lining of the stomach, providing a buffer
![Page 7: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/7.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sites of Actions of Drugs Affecting Gastrointestinal Secretions
Sites of Actions of Drugs Affecting Gastrointestinal Secretions
![Page 8: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/8.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Histamine-2 (H2) AntagonistsHistamine-2 (H2) Antagonists
• Actions
– Selectively block histamine-2 receptor sites
– This blocking leads to a reduction in gastric acid secretion and reduction in overall pepsin production
• Indications
– Short-term treatment of active duodenal ulcer or benign gastric ulcer
– Treatment of pathological hypersecretory conditions such as Zollinger–Ellison syndrome
– Prophylaxis of stress-induced ulcers and acute upper GI bleeding in critical patients
![Page 9: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/9.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Histamine-2 (H2) Antagonists (cont.)Histamine-2 (H2) Antagonists (cont.)
• Indications (cont.)
– Treatment of erosive gastroesophageal reflux
– Relief of symptoms of heartburn, acid indigestion, and sour stomach (OTC preparations)
• Pharmacokinetics
– Readily absorbed after oral administration
– Metabolized in the liver and excreted in urine
• Contraindications
– Known allergy
![Page 10: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/10.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Histamine-2 (H2) Antagonists (cont.)Histamine-2 (H2) Antagonists (cont.)• Caution
– Pregnancy or lactation
– Hepatic or renal dysfunction
• Adverse Effects
– GI effects
– CNS effects
– Cardiac arrhythmias and hypotension
• Drug-to-Drug Interactions
– Warfarin, phenytoin, beta blockers, alcohol, quinidine, lidocaine, theophylline, chloroquine, benzodiazepines, nifedipine, pentoxifylline, tricyclics, procainamide, and carbamazepine
![Page 11: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/11.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
Drugs act in several ways on the secretions of the GI tract. Which action affects the GI secretions least?
A. Decreases secretory activity
B. Blocks secretions
C. Replaces secretions
D. Prevents erosions
![Page 12: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/12.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
C. Replaces secretions
Rationale: The effects of drugs on GI secretions: decrease GI secretory activity; block the action of GI secretions; form protective coverings on the GI lining to prevent erosion from GI secretions; replace missing GI enzymes that the GI tract or ancillary glands and organs can no longer produce
![Page 13: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/13.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AntacidsAntacids• Actions
– Neutralize stomach acid by direct chemical reaction
• Indications
– Symptomatic relief of upset stomach associated with hyperacidity, as well as hyperactivity
• Contraindications
– Allergy
• Caution
– Any condition that can be exacerbated by electrolyte imbalance
– GI obstruction
![Page 14: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/14.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antacids (cont.)Antacids (cont.)• Adverse Effects
– Relate to their effects on acid-base levels and electrolytes
– Rebound acidity
– Alkalosis
– Hypercalcemia
– Constipation or diarrhea
– Hypophosphatemia
• Drug-to-Drug Interactions
– Affect the absorption of many other drugs
![Page 15: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/15.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Proton Pump InhibitorsProton Pump Inhibitors• Actions
– Act at specific secretory surface receptors to prevent the final step of acid production and thereby decrease the level of acid in the stomach
• Indications
– Short-term treatment of active duodenal ulcers, GERD, erosive esophagitis, and benign active gastric disease
– Long-term treatment of pathological hypersecretory conditions
• Pharmacokinetics
– Acid labile, rapidly absorbed in the GI tract
– Metabolized in the liver and excreted in the urine
![Page 16: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/16.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Proton Pump Inhibitors (cont.)Proton Pump Inhibitors (cont.)
• Contraindications
– Allergy
• Caution
– Pregnancy or lactation
• Adverse Effects
– CNS effects
• Dizziness, headache, asthenia, vertigo, insomnia, apathy
![Page 17: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/17.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Proton Pump Inhibitors (cont.)Proton Pump Inhibitors (cont.)
• Adverse Effects (cont.)
– GI Effects
• Diarrhea, abdominal pain, and tongue atrophy
– Upper respiratory tract symptoms
• Cough, stuff nose, hoarseness, and epistaxis
– Other
• Rash, alopecia, pruritis, dry skin, back pain, and fever
![Page 18: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/18.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antipeptic AgentAntipeptic Agent• Actions
– Forms an ulcer-adherent complex at duodenal ulcer sites, protecting the sites against acid, pepsin, and bile salts
• Indications
– Promote ulcer healing
• Pharmacokinetics
– Rapidly absorbed, metabolized in the liver, and excreted in feces
• Contraindications
– Allergy
– Renal failure
![Page 19: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/19.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antipeptic Agent (cont.)Antipeptic Agent (cont.)• Caution
– Pregnancy or lactation
• Adverse Effects
– GI effects – Constipation, diarrhea, nausea, indigestion, gastric discomfort, dry mouth
– Dizziness
– Sleepiness
– Vertigo
– Skin rash
– Back pain
![Page 20: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/20.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antipeptic Agent (cont.)Antipeptic Agent (cont.)
• Drug-to-Drug Interactions
– Aluminum salts
– Phenytoin, fluoroquinolone, or penicillamine
![Page 21: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/21.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
ProstaglandinProstaglandin• Actions
– Inhibits gastric acid secretion and increases bicarbonate and mucous production in the stomach
• Indications
– Prevention of NSAID-induced gastric ulcers
– Treatment of duodenal ulcers
• Pharmacokinetics
– Rapidly absorbed from GI tract, metabolized in the liver, and excreted in the urine
• Contraindications
– Pregnancy
![Page 22: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/22.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prostaglandin (cont.)Prostaglandin (cont.)
• Caution
– Lactation
• Adverse Effects
– GI effects – Nausea, diarrhea, abdominal pain, flatulence, vomiting, dyspepsia, and constipation
– GU effects – Miscarriages, excessive bleeding, spotting, cramping, hypermenorrhea, dysmenorrhea, and other menstrual disorders
![Page 23: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/23.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
Please answer the following statement as true or false.
There is a drug-drug interaction between the antipeptides and penicillin.
![Page 24: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/24.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
False
Rationale: Drug-to-drug interactions include aluminum salts, phenytoin, fluoroquinolone, or penicillamine.
![Page 25: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/25.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Patients Who May Require Digestive Enzyme Supplements
Patients Who May Require Digestive Enzyme Supplements
• Saliva Supplements
– Stroke
– Salivary gland disorder
– Extreme surgery of the head and neck
• Pancreatic Enzyme Supplements
– Common duct problems
– Pancreatic disease
– Cystic fibrosis
![Page 26: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/26.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Digestive EnzymesDigestive Enzymes
• Actions
– Saliva substitute – Contains electrolytes and carboxymethylcellulose to act as a thickening agent in dry mouth conditions
– Pancreatic enzymes are replacement enzymes that help the digestion and absorption of fats, proteins, and carbohydrates
• Indications
– Replacement therapy
![Page 27: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/27.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Digestive Enzymes (cont.)Digestive Enzymes (cont.)
• Contraindications
– Saliva – Allergy
– Pancreatic enzymes - Allergy
• Caution
– Saliva – CHF, hypertension, or renal failure
– Pancreatic enzyme – Pregnancy and lactation
![Page 28: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/28.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Digestive Enzymes (cont.)Digestive Enzymes (cont.)
• Adverse Effects
– Saliva – Complications from abnormal electrolytes – increased levels of magnesium, sodium, or potassium
– Pancreatic enzyme – GI irritation, nausea, abdominal cramps, and diarrhea
![Page 29: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/29.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Use of Agents Affecting Gastrointestinal Secretions Across the Lifespan
Use of Agents Affecting Gastrointestinal Secretions Across the Lifespan
![Page 30: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/30.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Histamine-2 (H2) AntagonistsPrototype Histamine-2 (H2) Antagonists
![Page 31: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/31.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype AntacidsPrototype Antacids
![Page 32: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/32.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Proton Pump InhibitorsPrototype Proton Pump Inhibitors
![Page 33: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/33.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Digestive EnzymesPrototype Digestive Enzymes
![Page 34: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/34.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
What H2 antagonist has been associated with antiandrongenic effects?
A. Famotidine
B. Cimetidine
C. Nizatidine
D. Ranitidine
![Page 35: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/35.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
B. Cimetidine
Rationale: Cimetidine was the first drug in this class to be developed. It has been associated with antiandrongenic effects, including gynecomastia and galactorrhea.
![Page 36: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/36.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Histamine-2 (H2) Antagonists
Nursing Considerations for Histamine-2 (H2) Antagonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
![Page 37: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/37.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for AntacidsNursing Considerations for Antacids
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
![Page 38: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/38.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Proton Pump Inhibitors
Nursing Considerations for Proton Pump Inhibitors
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
![Page 39: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/39.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Antipeptic Agent
Nursing Considerations for Antipeptic Agent
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
![Page 40: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/40.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Prostaglandin Nursing Considerations for Prostaglandin
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
![Page 41: Ppt chapter 57](https://reader031.vdocument.in/reader031/viewer/2022012400/54816c845906b50e6d8b467c/html5/thumbnails/41.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Digestive Enzymes
Nursing Considerations for Digestive Enzymes
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation